Where Global Leaders Meet China's Healthcare Innovators
Register Now
What to Expect
GHIS bridges East and West, connecting international pharmaceutical, medtech, and healthcare companies through curated partnering, transaction roadshows, and strategic networking.
Unrivaled Networking
Connect with 500+ attendees from across the biopharma, medtech, life sciences and investment sectors through 1000+ 1-on-1 meetings.
Cutting-Edge Content
Gain insights from top industry experts on biopharma & medtech trends, investment landscape, market expansion, and cross-border dealmaking.
Investment & Deal-Making Opportunities
Explore funding strategies, IPO potential, and M&A trends shaping APAC’s biopharma & medtech landscape, with 300+ unique companies in attendance and 100+ licensing opportunities.
Global Market Access
Learn how to navigate regulatory pathways and successfully expand into international markets, with participants from all over the world.
Four Tracks. One Ecosystem.
Biopharmaceuticals | Medical Devices | Digital Health & AI | Life Sciences
0
Global Participating Companies
0
GHIS Transaction Roadshows
0
Industry Leaders & Speakers
0
Investment Institutions & Strategic Investors
0
Technology Forums & Panel Discussions
0
1-on-1 Partnering Meetings
Trusted By The Companies Pioneering What's Next
2026 Speakers & Attendees
Industry-leading executives from MNCs, emerging companies, capital firms, and more.
Dan Liu Managing Partner, China Pivotal bioVenture Partners China
Amit Kakar Managing Partner Novo Holdings Asia
Jeffery Li Founding Partner & CEO GL Capital
Joel Yao Partner Sofinnova Partners - Biovelocita Strategy
Jason Peng Global Vice President, Danaher Corporation, and Group President of the China Region Danaher
Raju Kucherlapati Paul C. Cabot Professor of Genetics and Professor of Medicine Harvard Medical School
Daniel Nothelfer Vice President, Business Development & Strategy, Life Sciences Innovations Group Danaher
Robert King Co-Founder and Chief Investment Officer 1540 Ventures
Qiyu Chen Executive Director and Co-Chief Executive Officer Fosun International
Guohong Shan SVP, GM, Greater China, Central and South Asia BeOne Medicines
Alex Gu Senior Vice President and President of Greater China Medtronic
Rogier Janssens President of Merck China and Managing Director of Merck Life Science China Merck
Eric Xin Senior Managing Director Trustar Capital
Ling Liu Chief Region Leader Philips Greater China
John Xu Founder and President Biorich International
Yihao Zhang Managing Director Warburg Pincus Asia
Lei Shi Senior Partner, Co-Head of China Healthcare Investment Eight Roads Venture China
Can Cui Shareholder Greenberg Traurig, LLP.
Theresa Tse Chairwoman Sino Biopharmaceutical
Marie Zhu Executive Vice President & Chief Technology Officer WuXi XDC
Muzi Weng Managing Director, Head of Asia Pharmaceuticals Research Citi
Feng Ren Co-CEO and Chief Scientific Officer Insilico Medicine
Sandy Mou Board Executive Director and CEO Corxel
Jay Wang CEO EverBridge Group
Helen Chen Global Sector Co-Head, Healthcare and Life Sciences, Head of Asia Healthcare, Greater China Managing Partner L.E.K. Consulting
Cui Cui Managing Director and Head of Asia Healthcare Jefferies
Zheng Zang Executive Director, Investment Banking Morgan Stanley
Kenneth Sun Senior Vice President & Head of Asia Royalty Pharma
Yaming Wang Founder and CEO Alphabet Health Group
Adele Chen Founder, MedTrend; Executive Chair, GHIS MedTrend
Xiaobin Hu Senior Director, Investments Boehringer Ingelheim Venture Fund Asia
Ty Hu Founder and Chairman Gateway Medical Innovation Center
Sean Huang CEO Beijing Taikang Investment
Qinghui Yuan Co-Head, Pharmaceuticals & Healthcare Research Group, Research and Development Department; Chief Healthcare Analyst; Chief Analyst, Pharmaceuticals & Biotechnology China Securities Co., Ltd.
Xingpeng Wang President Shanghai Hospital Association (SHA)
Issei Tsukamoto Senior Vice President, Head of Business Development Astellas Pharma Inc.
Michael Yang Senior Vice-President (Innovation and Enterprise) City University of Hong Kong (CityU)
Ying Mao President Huashan Hospital, Fudan University
Guangzhong Yang Founder and Chief Scientist Institute of Medical Robotics at Shanghai Jiao Tong University
Sze-Chuen Cesar Wong Associate Vice-President (Research) and Director, School of Biological Sciences The University of Hong Kong
Chenxi Ouyang Director of the Institute of Cellular Immunotherapy Sino-US Precision Medicine Research Institute
Ruijun Tian Chair Professor of Chemistry and Director, Technology Transfer Center Southern University of Science and Technology
2026 Presenting Companies
Present to a full house of investors and strategics alongside the
CEOs and Founders building technology that is shaping the
future of healthcare.
Plan Your Stay in
Hong Kong
GHIS 2026 HK will be held at Grand Hyatt Hong Kong. In addition to the venue hotel, GHIS will provide registered attendees with access to selected nearby hotels at preferred rates, covering a range of accommodation options to suit different budgets, schedules, and travel preferences.
Learn More
Connecting Global Healthcare
Innovation Beyond the Annual Summit
GHIS is committed to building a connected international platform where innovators, industry leaders,
investors and healthcare organizations can engage throughout the year-not only during the annual
summit, but also at key moments across the global healthcare calendar.
2027
January
J.P. Morgan Healthcare Week
GHIS Satellite Program
June
American Society of Clinical Oncology (ASCO)
GHIS Satellite Program
 
The American Diabetes Association's (ADA's) Scientific Sessions
GHIS Satellite Program
October
Global Healthcare Innovation Summit (GHIS)
Annual Flagship Summit
 
Transcatheter Cardiovascular Therapeutics® Conference (TCT)
GHIS Satellite Program
More to Come
Additional Global Healthcare Conferences
Future GHIS Programs
GHIS 2025 Photo Highlights
GHIS provides a valuable window into emerging healthcare innovation and a highly efficient way to meet companies that are ready for global partnerships.
Head of Search & Evaluation, Global Pharma
GHIS stands out for its ability to connect scientific innovation with industry and capital. It is a valuable platform for companies looking to expand internationally.
Founder, Life Science Company
One of the few events where meaningful partnership discussions can happen in a highly efficient setting.
VP Business Development, Global MedTech